Marrone Bio Innovations Inc. (NASDAQ:MBII) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Wednesday.

According to Zacks, “Marrone Bio Innovations Inc. develops environmentally safe bio-based products. The Company specializes in the discovery, development, and marketing of natural products for weed, pest, water resource, and plant disease management. It offers crop protection products for conventional and organic crop production, including herbicides for weed control, fungicides for plant disease control, nematicides for parasitic roundworm control, insecticides for insect and mite killers and plant growth regulators that growers use to increase crop yields, enhance plant health, manage pest resistance, and reduce chemical residues. Marrone Bio Innovations Inc. is headquartered in Davis, California. “

Marrone Bio Innovations (NASDAQ:MBII) opened at 1.67 on Wednesday. The firm’s market capitalization is $41.11 million. Marrone Bio Innovations has a one year low of $0.60 and a one year high of $3.76. The firm has a 50-day moving average price of $1.61 and a 200-day moving average price of $1.03.

Marrone Bio Innovations (NASDAQ:MBII) last announced its quarterly earnings data on Tuesday, August 9th. The company reported ($0.28) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.28). The business earned $5 million during the quarter, compared to the consensus estimate of $4.61 million. Marrone Bio Innovations had a negative return on equity of 2,083.14% and a negative net margin of 304.71%. Equities analysts anticipate that Marrone Bio Innovations will post ($1.12) earnings per share for the current year.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

5 Day Chart for NASDAQ:MBII

Receive News & Stock Ratings for Marrone Bio Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations Inc. and related stocks with our FREE daily email newsletter.